PLUS1
Best deals to access real time data! |
|
SMALL CAP BASIC
Monthly Subscription
for only
|
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Guided Therapeutics, Inc. | GTHP | Other OTC | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.01435 | 7.33% | 0.21 | 0.22 | 0.20 | 0.20 | 0.19565 | 16:00:06 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.14 | 0.25 | 0.11 | 44.00% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 13 | 20,494 | $ 0.203355 | $ 4,168 | 14,180 | 0.10 - 0.2645 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:15:09 | 11 | $ 0.2075 | USD |
Guided Therapeutics, Inc. Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 697.09k | 3.32M | $ 1.02M | - | 0.69 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Guided Therapeutics, Inc. News
| Date | Time | Source | News Article |
|---|---|---|---|
| 5/15/2019 | 15:08 | Edgar (US Regulatory) | Notification That Quarterly Report Will Be Submitted Late.. |
| 5/08/2019 | 17:25 | Edgar (US Regulatory) | Annual Report (10-k) |
| 9/17/2018 | 15:40 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) |
| 9/06/2018 | 13:23 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 9/05/2018 | 12:08 | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting.. |
| 7/11/2018 | 06:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) |
| 6/14/2018 | 12:46 | Edgar (US Regulatory) | Securities Registration Statement (s-1) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GTHP Price Data
| Period † | Open | High | Low | VWAP | Min Vol | Max Vol | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|---|---|
| 1 Week | 0.17 | 0.22 | 0.155 | 0.1699 | 2k | 40k | 14k | 0.04 | 23.53% |
| 1 Month | 0.16412 | 0.2645 | 0.1308 | 0.1830 | 2k | 67k | 20k | 0.04588 | 27.96% |
| 3 Months | 0.15 | 0.2645 | 0.1 | 0.1622 | 2k | 99k | 27k | 0.06 | 40.00% |
| 6 Months | 0.15 | 0.2645 | 0.1 | 0.1622 | 2k | 99k | 27k | 0.06 | 40.00% |
| 1 Year | 0.15 | 0.2645 | 0.1 | 0.1622 | 2k | 99k | 27k | 0.06 | 40.00% |
| 3 Years | 0.15 | 0.2645 | 0.1 | 0.1622 | 2k | 99k | 27k | 0.06 | 40.00% |
| 5 Years | 0.476 | 0.55 | 0.0055 | 0.0551 | 2k | 25M | 1M | -0.266 | -55.88% |
Guided Therapeutics, Inc. Description
| Guided Therapeutics, Inc. is the developer of the LuViva Advanced Cervical Scan, a rapid and painless test for the early detection of disease that leads to cervical cancer. LuViva is designed to quickly eliminate false positive Pap and HPV results and discover cervical disease missed by existing tests. LuViva works by shining light on the cervical and reading the returned light with a spectrometer. LuViva looks for chemical and physical markers of precancer. Unlike Pap and HPV tests, the device does not require a painful tissue sample and results are known immediately. For more information, visit www.guidedinc.com. |
